Managing non-paraneoplastic Lambert–Eaton myasthenic syndrome: Clinical characteristics in 25 German patients
Hannah L. Pellkofer, Lena Armbruster, Rainer Linke, Friedrich Schumm, Raymond Voltz
20091101
2009 Dec 1
J Neuroimmunol
Managing non-paraneoplastic Lambert–Eaton myasthenic syndrome: Clinical characteristics in 25 German patients
J Neuroimmunol. 2009 Dec 10;217(1-2):90-94, Hannah L. Pellkofer, Lena Armbruster, Rainer Linke, Friedrich Schumm, Raymond Voltz
In about 40% of patients LEMS is not a paraneoplastic phenomenon (NT-LEMS). Several clinical aspects important to these patients remain open, especially the question when a LEMS can definitely be diagnosed as NT-LEMS. Here we describe a series of 25 German NT-LEMS patients regarding their clinical characteristics, duration of symptoms, value of serological markers, paraneoplastic antibodies and FDG-PET/CT. Furthermore, we discuss the current diagnostic criteria of NT-LEMS.
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
